Candriam SCA’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-460,436
| Closed | -$4.65M | – | 895 |
|
|
2022
Q4 | $4.65M | Hold |
460,436
| – | – | 0.03% | 394 |
|
|
2022
Q3 | $10.3M | Buy |
460,436
+236,403
| +106% | +$5.3M | 0.07% | 262 |
|
|
2022
Q2 | $5.55M | Sell |
224,033
-19,407
| -8% | -$481K | 0.05% | 313 |
|
|
2022
Q1 | $9.44M | Sell |
243,440
-7,297
| -3% | -$283K | 0.06% | 267 |
|
|
2021
Q4 | $14.7M | Hold |
250,737
| – | – | 0.09% | 214 |
|
|
2021
Q3 | $14.9M | Hold |
250,737
| – | – | 0.1% | 217 |
|
|
2021
Q2 | $21.8M | Sell |
250,737
-19,370
| -7% | -$1.68M | 0.15% | 163 |
|
|
2021
Q1 | $23.6M | Sell |
270,107
-4
| -0% | -$349 | 0.2% | 132 |
|
|
2020
Q4 | $24.6M | Buy |
+270,111
| New | +$24.6M | 0.19% | 133 |
|